These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25324169)

  • 1. High expression of transcriptional factor HoxB9 predicts poor prognosis in patients with lung adenocarcinoma.
    Zhan J; Wang P; Niu M; Wang Y; Zhu X; Guo Y; Zhang H
    Histopathology; 2015 Jun; 66(7):955-65. PubMed ID: 25324169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated HOXB9 expression promotes differentiation and predicts a favourable outcome in colon adenocarcinoma patients.
    Zhan J; Niu M; Wang P; Zhu X; Li S; Song J; He H; Wang Y; Xue L; Fang W; Zhang H
    Br J Cancer; 2014 Aug; 111(5):883-93. PubMed ID: 25025961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6.
    Wan J; Xu W; Zhan J; Ma J; Li X; Xie Y; Wang J; Zhu WG; Luo J; Zhang H
    Nucleic Acids Res; 2016 Dec; 44(22):10662-10675. PubMed ID: 27613418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HOXB9 promotes endometrial cancer progression by targeting E2F3.
    Wan J; Liu H; Feng Q; Liu J; Ming L
    Cell Death Dis; 2018 May; 9(5):509. PubMed ID: 29724991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOXB9 enhances the ability of lung cancer cells to penetrate the blood-brain barrier.
    Zheng H; Li C; Li Z; Zhu K; Bao H; Xiong J; Liang P
    Aging (Albany NY); 2020 Dec; 13(4):4999-5019. PubMed ID: 33411683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
    Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinoma.
    Kwon OS; Oh E; Park JR; Lee JS; Bae GY; Koo JH; Kim H; Choi YL; Choi YS; Kim J; Cha HJ
    Oncotarget; 2015 Dec; 6(39):41916-28. PubMed ID: 26544896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial-Mesenchymal Transition.
    Pang B; Wu N; Guan R; Pang L; Li X; Li S; Tang L; Guo Y; Chen J; Sun D; Sun H; Dai J; Bai J; Ji G; Liu P; Liu A; Wang Q; Xiao S; Fu S; Jin Y
    Clin Cancer Res; 2017 Sep; 23(18):5598-5610. PubMed ID: 28606921
    [No Abstract]   [Full Text] [Related]  

  • 9. USP22 promotes tumor progression and induces epithelial-mesenchymal transition in lung adenocarcinoma.
    Hu J; Yang D; Zhang H; Liu W; Zhao Y; Lu H; Meng Q; Pang H; Chen X; Liu Y; Cai L
    Lung Cancer; 2015 Jun; 88(3):239-45. PubMed ID: 25907317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of E-cadherin in pleural effusion cells predicts better prognosis in lung adenocarcinoma patients.
    Zhao C; Li X; Su C; Li J; Cheng N; Ren S; Chen X; Zhou C
    Int J Clin Exp Pathol; 2015; 8(3):3104-9. PubMed ID: 26045824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma.
    Mo ML; Okamoto J; Chen Z; Hirata T; Mikami I; Bosco-Clément G; Li H; Zhou HM; Jablons DM; He B
    PLoS One; 2013; 8(8):e71816. PubMed ID: 23977152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α1-antitrypsin promotes lung adenocarcinoma metastasis through upregulating fibronectin expression.
    Li Y; Miao L; Yu M; Shi M; Wang Y; Yang J; Xiao Y; Cai H
    Int J Oncol; 2017 Jun; 50(6):1955-1964. PubMed ID: 28440399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated nuclear CCND1 expression confers an unfavorable prognosis for early stage lung adenocarcinoma patients.
    Xu P; Zhao M; Liu Z; Liu Y; Chen Y; Luo R; Fang W
    Int J Clin Exp Pathol; 2015; 8(12):15887-94. PubMed ID: 26884860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TWIST1 upregulates miR-214 to promote epithelial-to-mesenchymal transition and metastasis in lung adenocarcinoma.
    Liu C; Luo J; Zhao YT; Wang ZY; Zhou J; Huang S; Huang JN; Long HX; Zhu B
    Int J Mol Med; 2018 Jul; 42(1):461-470. PubMed ID: 29693173
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Martinou E; Moller-Levet C; Karamanis D; Bagwan I; Angelidi AM
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of HOXB9 is related to poor overall survival in patients with gastric carcinoma.
    Sha S; Gu Y; Xu B; Hu H; Yang Y; Kong X; Wu K
    Dig Liver Dis; 2013 May; 45(5):422-9. PubMed ID: 23332081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma.
    Guo T; Zhao S; Li Z; Li F; Li J; Gu C
    Cancer Biomark; 2018; 22(2):301-310. PubMed ID: 29630522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOXB9 induction of mesenchymal-to-epithelial transition in gastric carcinoma is negatively regulated by its hexapeptide motif.
    Chang Q; Zhang L; He C; Zhang B; Zhang J; Liu B; Zeng N; Zhu Z
    Oncotarget; 2015 Dec; 6(40):42838-53. PubMed ID: 26536658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Huntingtin-Interacting Protein-1 Is an Early-Stage Prognostic Biomarker of Lung Adenocarcinoma and Suppresses Metastasis via Akt-mediated Epithelial-Mesenchymal Transition.
    Hsu CY; Lin CH; Jan YH; Su CY; Yao YC; Cheng HC; Hsu TI; Wang PS; Su WP; Yang CJ; Huang MS; Calkins MJ; Hsiao M; Lu PJ
    Am J Respir Crit Care Med; 2016 Apr; 193(8):869-80. PubMed ID: 26595459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of SIX1 is an independent prognostic marker in stage I-III colorectal cancer.
    Kahlert C; Lerbs T; Pecqueux M; Herpel E; Hoffmeister M; Jansen L; Brenner H; Chang-Claude J; Bläker H; Kloor M; Roth W; Pilarsky C; Rahbari NN; Schölch S; Bork U; Reissfelder C; Weitz J; Aust D; Koch M
    Int J Cancer; 2015 Nov; 137(9):2104-13. PubMed ID: 25951369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.